ML399

CAS No. 1560968-49-1

ML399 ( VU0516340 )

Catalog No. M12219 CAS No. 1560968-49-1

ML399 (VU0516340) is a potent and cell penetrant menin-MLL inhibitor with IC50 of 90 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ML399
  • Note
    Research use only, not for human use.
  • Brief Description
    ML399 (VU0516340) is a potent and cell penetrant menin-MLL inhibitor with IC50 of 90 nM.
  • Description
    ML399 (VU0516340) is a potent and cell penetrant menin-MLL inhibitor with IC50 of 90 nM; shows improved potency and DMPK properties; a chemical probe for in vivo proof-of-mechanism studies.
  • Synonyms
    VU0516340
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1560968-49-1
  • Formula Weight
    445.54
  • Molecular Formula
    C27H28FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=CC=C(OCCCN2CCC([C@@](O)(C3=CC=CC(F)=C3)C4=NC=CC=C4)CC2)C=C1
  • Chemical Name
    (R)-4-(3-(4-((3-Fluorophenyl)(hydroxy)(pyridin-2-yl)methyl)piperidin-1-yl)propoxy)benzonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Senter T, et al. Probe Reports from the NIH Molecular Libraries Program [Internet].
2. Senter T, et al. Bioorg Med Chem Lett. 2015 Jul 1;25(13):2720-5.
molnova catalog
related products
  • ML399

    ML399 (VU0516340) is a potent and cell penetrant menin-MLL inhibitor with IC50 of 90 nM.

  • EPZ-031686

    A potent, selective, small molecule SMYD3 inhibitor (Biochem IC50=3 nM; Cell IC50= 36 nM).

  • UNC1999

    UNC1999 is a potent, orally bioavailable and selective inhibitor of EZH2 and EZH1 with IC50 of 2 nM and 45 nM in cell-free assays, respectively.